ctrl K

Watchlist Price Alert

Lyell Immunopharma Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

0.41

0.01 (1.33%)

At close: May 14, 2025, 3:59 PM

0.39

-3.82%

After-hours: May 14, 2025, 04:20 PM EDT

Lyell Immunopharma Revenue Breakdown

Period Ending	Dec 31, 2024
Reportable segment Revenue	61K
Reportable segment Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	14.52M	11.77M	12.26M	13.49M	13.17M	15.51M	19.03M	19.28M	26.35K	26.08M	30.45M	34.42M	31.87M	21.24M	19.11M	16.83M	14.87M	13.57M	9.56M	8.88M
Selling, General, and Administrative Revenue Growth	+23.39%	-3.97%	-9.17%	+2.48%	-15.09%	-18.51%	-1.29%	+73070.64%	-99.90%	-14.35%	-11.52%	+7.99%	+50.05%	+11.14%	+13.55%	+13.20%	+9.57%	+41.92%	+7.68%	n/a
Research and Development Revenue	48.67M	39.5M	36.15M	37.63M	41.62M	43.85M	47.47M	44.63M	38.03K	41.61M	43.72M	35.83M	19.29M	31.43M	46.45M	41.53M	35.09M	24.5M	97.15M	25.5M
Research and Development Revenue Growth	+23.21%	+9.26%	-3.91%	-9.60%	-5.09%	-7.63%	+6.37%	+117248.55%	-99.91%	-4.83%	+22.02%	+85.79%	-38.65%	-32.32%	+11.84%	+18.35%	+43.22%	-74.78%	+280.99%	n/a